Home DailyMed 7fe70118-ec04-40c6-8582-04ad416c2fe2 AMLODIPINE and OLMESARTAN MEDOXOMIL Tablets Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer Zydus Lifesciences Limited
Effective date 2022-10-13
Label type HUMAN PRESCRIPTION DRUG LABEL
Version 4
Source legacy-cache
Hydrated at 2026-08-01 21:51:41 Label at a glance# Product Amlodipine and olmesartan medoxomil
Active ingredient AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL
Label structure 1 sections
Products# Every source-derived product name is available through these pages.
DailyMed product names page 1 of 1 · 19 matching rows.
Amlodipine and olmesartan medoxomil AMLODIPINE BESYLATE AMLODIPINE OLMESARTAN MEDOXOMIL OLMESARTAN ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE NDC Codes# Product NDC, Package NDC table Product NDC Package NDC 70771-1186 70771-1186-3 , 70771-1186-9 , 70771-1186-1 , 70771-1186-5 , 70771-1186-0 70771-1187 70771-1187-3 , 70771-1187-9 , 70771-1187-1 , 70771-1187-5 , 70771-1187-0 , 70771-1187-2 , 70771-1187-4 70771-1188 70771-1188-3 , 70771-1188-9 , 70771-1188-1 , 70771-1188-5 , 70771-1188-0 , 70771-1188-2 , 70771-1188-4 70771-1189 70771-1189-3 , 70771-1189-9 , 70771-1189-1 , 70771-1189-5 , 70771-1189-0 , 70771-1189-2 , 70771-1189-4
Ingredients# Every source-derived ingredient row is available through these pages.
DailyMed ingredient rows page 1 of 2 · 59 matching rows.
Name, UNII, Kind table Name UNII Kind AMLODIPINE BESYLATE 864V2Q084H ACTIM OLMESARTAN MEDOXOMIL 6M97XTV3HD ACTIB ANHYDROUS LACTOSE 3SY5LH9PMK IACT CELLULOSE, MICROCRYSTALLINE OP1R32D61U IACT CROSCARMELLOSE SODIUM M28OL1HH48 IACT HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED 2165RE0K14 IACT HYPROMELLOSES 3NXW29V3WO IACT MAGNESIUM STEARATE 70097M6I30 IACT POLYETHYLENE GLYCOL, UNSPECIFIED 3WJQ0SDW1A IACT SILICON DIOXIDE ETJ7Z6XBU4 IACT STARCH, CORN O8232NY3SJ IACT TALC 7SEV7J4R1U IACT TITANIUM DIOXIDE 15FIX9V2JP IACT AMLODIPINE BESYLATE 864V2Q084H ACTIM OLMESARTAN MEDOXOMIL 6M97XTV3HD ACTIB ANHYDROUS LACTOSE 3SY5LH9PMK IACT CELLULOSE, MICROCRYSTALLINE OP1R32D61U IACT CROSCARMELLOSE SODIUM M28OL1HH48 IACT FERRIC OXIDE RED 1K09F3G675 IACT FERRIC OXIDE YELLOW EX438O2MRT IACT HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED 2165RE0K14 IACT HYPROMELLOSES 3NXW29V3WO IACT MAGNESIUM STEARATE 70097M6I30 IACT POLYETHYLENE GLYCOL, UNSPECIFIED 3WJQ0SDW1A IACT SILICON DIOXIDE ETJ7Z6XBU4 IACT STARCH, CORN O8232NY3SJ IACT TALC 7SEV7J4R1U IACT TITANIUM DIOXIDE 15FIX9V2JP IACT AMLODIPINE BESYLATE 864V2Q084H ACTIM OLMESARTAN MEDOXOMIL 6M97XTV3HD ACTIB ANHYDROUS LACTOSE 3SY5LH9PMK IACT CELLULOSE, MICROCRYSTALLINE OP1R32D61U IACT CROSCARMELLOSE SODIUM M28OL1HH48 IACT FERRIC OXIDE RED 1K09F3G675 IACT FERRIC OXIDE YELLOW EX438O2MRT IACT FERROSOFERRIC OXIDE XM0M87F357 IACT HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED 2165RE0K14 IACT HYPROMELLOSES 3NXW29V3WO IACT MAGNESIUM STEARATE 70097M6I30 IACT POLYETHYLENE GLYCOL, UNSPECIFIED 3WJQ0SDW1A IACT
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207771-001 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;20MG TABLET / ORAL AB 2017-09-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207771-002 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG TABLET / ORAL AB 2017-09-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207771-003 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;20MG TABLET / ORAL AB 2017-09-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207771-004 AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 10MG BASE;40MG TABLET / ORAL AB 2017-09-22 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 180 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.